SEP 30, 2019 8:41 AM PDT

New Potential Early Stage Treatment for Parkinson's

WRITTEN BY: Annie Lennon

Parkinson’s Disease is the second most common neurodegenerative condition, affecting 35 million people globally. Currently without a cure, researchers from Stanford University have identified a molecular defect common to all people with the condition that may help pave the way for early diagnosis and new treatment options. 

In a study published in Cell Metabolism, researchers collected skin samples from 83 people with Parkinson’s, five asymptomatic close relatives thought to be at high risk of developing the condition, 22 people with other movement disorders and 52 healthy control subjects. Extracting the fibroblasts from the skin samples, they then cultured them in petri dishes and put them under stress to damage their mitochondria. Under normal circumstances, this process leads to the removal of Miro, an adaptor molecule, from damaged mitochondria, so they may then be repaired by the body (Hsieh: 2019). 

Although Miro was successfully removed from damaged mitochondria in the control group and those with other movement disorders, for those with Parkinson’s and their high risk relatives, the Miro remained. A clear indicator of how the early stages of Parkinson’s begin- by disabling the body from repairing damaged mitochondria, the researchers recognised that simple tests like this may help with early diagnosis of Parkinsons. Yet, they didn’t stop with this conclusion (ibid.). 

Screening 6,835,320 molecules, they used software from Atomwise to identify 11 molecules possibly capable of binding to Miro to facilitate its separation from mitochondria, that were nontoxic, orally available and able to cross the blood-brain barrier. Testing these compounds on fruit flies for seven days, the researchers found that four of them significantly reduced their Miro levels without negative side effects. Furthermore, the researchers also tested one compound on fibroblasts from a patient with sporadic Parkinson’s disease, noting substantial improvements on Miro clearance in their cells after their mitochondria was damaged. 

Although further research is needed to confirm the results, Xinnan Wang, the study’s senior author, “Our hope is that if this compound or a similar one proves nontoxic and efficacious and we can give it, like a statin drug, to people who’ve tested positive for the Miro-removal defect but don’t yet have Parkinson’s symptoms, they’ll never get it. (Stanford Medicine: 2019)”

 

Sources

 

Hsieh, Chung-Han et al: Cell Metabolism

Stanford Medicine 

 

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
SEP 20, 2020
Drug Discovery & Development
Cholesterol-Lowering Drugs Reduce The Severity of COVID-19
SEP 20, 2020
Cholesterol-Lowering Drugs Reduce The Severity of COVID-19
Almost a year into the beginnings of the COVID-19 pandemic and we still do not have a Food and Drug Administration (FDA) ...
OCT 01, 2020
Cancer
Understanding in vivo Metabolomics: C13 Isotope Studies
OCT 01, 2020
Understanding in vivo Metabolomics: C13 Isotope Studies
One key to understanding cancer metabolomics lies in the ability to accurately replicate the natural environment of the ...
OCT 12, 2020
Drug Discovery & Development
Researchers Solve Key Problem for Cancer Immunotherapy
OCT 12, 2020
Researchers Solve Key Problem for Cancer Immunotherapy
Cancer immunotherapies are becoming increasingly promising as a standard-of-care treatment. However, despite their promi ...
OCT 15, 2020
Cannabis Sciences
Can Cannabis Treat Traumatic Brain Injury?
OCT 15, 2020
Can Cannabis Treat Traumatic Brain Injury?
Traumatic brain injury (TBI) happens when the head is violently hit by an object or when an object pierces the skull and ...
OCT 27, 2020
Cardiology
Boron Could Prevent Myocardial Fibrosis and Assist in Recovery
OCT 27, 2020
Boron Could Prevent Myocardial Fibrosis and Assist in Recovery
When you pass by the nutrition section at the local grocery store, there is a chance you’ll come across row upon r ...
NOV 02, 2020
Immunology
New Cancer Drug Reboots Stalled Immunotherapies
NOV 02, 2020
New Cancer Drug Reboots Stalled Immunotherapies
In contrast to traditional chemotherapies, immunotherapies reprogram the patient’s own immune system to fight tumo ...
Loading Comments...